AVITA Medical (AVHHL) Depreciation & Amortization (CF) (2019 - 2025)

AVITA Medical (AVHHL) has reported Depreciation & Amortization (CF) for 7 consecutive years, with $700000.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Depreciation & Amortization (CF) rose 71.15% year-over-year to $700000.0; the trailing twelve-month figure through Jun 2026 stood at $1.8 million (up 1.9% YoY), and the FY2025 full-year result was $2.3 million, up 108.44% from the prior year.
• Depreciation & Amortization (CF) advanced to $700000.0 in Q4 2025 per AVHHL's latest filing, from $574000.0 in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $700000.0 in Q4 2025 and bottomed at -$242000.0 in Q4 2022.
• Historically, Depreciation & Amortization (CF) has averaged $297235.3 across 5 years, with a median of $204000.0 in 2024.
• The widest YoY moves for Depreciation & Amortization (CF): up 177.27% in 2023, down 17.18% in 2023.
• Over 5 years, Depreciation & Amortization (CF) stood at $517000.0 in 2021, then slumped by 146.81% to -$242000.0 in 2022, then jumped by 177.27% to $187000.0 in 2023, then surged by 118.72% to $409000.0 in 2024, then soared by 71.15% to $700000.0 in 2025.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $700000.0, $574000.0, and $552000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.